Antithrombotic therapy in patients with peripheral artery diseases
Svetlikov, A.V.; Sapelkin, S.V.; Ishpulaeva, L.É; Gorbunov, G.N.
Angiologiia i Sosudistaia Khirurgiia 24(3): 13-17
2018
ISSN/ISBN: 1027-6661 PMID: 30321141 Document Number: 697100
Complications of cardiovascular diseases whose substrate is atherothrombosis continue to occupy leading positions in the structure of mortality worldwide. Peripheral artery diseases (PAD), in particular, are characterized by an especially unfavourable life prognosis for patients with cardiovascular diseases. In order to decrease the risks of ischaemic complications in patients with PAD, various approaches to antithrombotic therapy have over the last two decades been studied, with the resulting standard of therapy continuing to be acetylsalicylic acid. Even more difficult today is the task of selecting antithrombotic therapy in patients having endured revascularization.